Viatrexx-Adipose is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Epinephrine; Bos Taurus Artery; Sus Scrofa Artery; Adenosine Triphosphate; Adenosine Cyclic Phosphate; Centella Asiatica; Citric Acid Monohydrate; Coenzyme A; Colchicum Autumnale Bulb; Fumaric Acid; Interleukin-10; Levocarnitine; Lactic Acid; Pancrelipase Lipase; Beef Liver; Pork Liver; Sus Scrofa Lymph; Bos Taurus Lymph; Sodium Diethyl Oxalacetate; Sodium Pyruvate; Sus Scrofa Pituitary Gland; Bos Taurus Pituitary Gland; Quinhydrone; Succinic Acid; Bos Taurus Parathyroid Gland; Sus Scrofa Parathyroid Gland; Bos Taurus Vein; Sus Scrofa Vein; Yohimbine; Ferrous Fumarate; Mecasermin; Potassium Aspartate; Momordica Balsamina Whole.
| Product ID | 73069-024_aa6d1c5c-dd65-40b6-bef4-d027a4a8d5e4 |
| NDC | 73069-024 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viatrexx-Adipose |
| Generic Name | Epinephrine , Artery , Metenkefalin , Adenosine Triphosphate , Adenosine Cyclic Phosphate , Centella Asiatica , Citric Acid Monohydrate , Coenzyme A , Colchicum Autumnale Bulb , Fumaric Acid , Interleukin-10 , Levocarnitine , Lactic Acid , Pancrelipase Lipase , Liver , Lymph, Sodium Diethyl Oxalacetate , Sodium Pyruvate , Pituitary Gland, Quinhydrone , Succinic Acid , Parathyroid Gland, Vein, Yohimbine, Ferrous Fumarate, Mecasermin, Potassium Aspartate And Momordica Balsamina Whole |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
| Marketing Start Date | 2019-03-29 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | VIATREXX BIO INCORPORATED |
| Substance Name | EPINEPHRINE; BOS TAURUS ARTERY; SUS SCROFA ARTERY; ADENOSINE TRIPHOSPHATE; ADENOSINE CYCLIC PHOSPHATE; CENTELLA ASIATICA; CITRIC ACID MONOHYDRATE; COENZYME A; COLCHICUM AUTUMNALE BULB; FUMARIC ACID; INTERLEUKIN-10; LEVOCARNITINE; LACTIC ACID; PANCRELIPASE LIPASE; BEEF LIVER; PORK LIVER; SUS SCROFA LYMPH; BOS TAURUS LYMPH; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA PITUITARY GLAND; BOS TAURUS PITUITARY GLAND; QUINHYDRONE; SUCCINIC ACID; BOS TAURUS PARATHYROID GLAND; SUS SCROFA PARATHYROID GLAND; BOS TAURUS VEIN; SUS SCROFA VEIN; YOHIMBINE; FERROUS FUMARATE; MECASERMIN; POTASSIUM ASPARTATE; MOMORDICA BALSAMINA WHOLE |
| Active Ingredient Strength | 31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Carnitine [CS],Carnitine Analog [EPC],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Ingredient | Strength |
|---|---|
| EPINEPHRINE | 31 [kp_C]/mL |